Complete Reference Genome Sequence of the Clinical Neisseria gonorrhoeae Strain H035, with Resistance to the Novel Antimicrobial Zoliflodacin, Identified in Japan in 2000.

Golparian D, Jacobsson S, Ohnishi M, Unemo M

Microbiol Resour Announc 12 (3) e0113022 [2023-03-16; online 2023-02-28]

Zoliflodacin is a promising novel antimicrobial in clinical development for treatment of gonorrhea; currently, it is in a global phase 3 randomized controlled clinical trial. High activity against global Neisseria gonorrhoeae strains has been shown. We present the complete reference genome of the zoliflodacin-resistant strain H035, which was identified in Japan in 2000.

Clinical Genomics Örebro [Collaborative]

PubMed 36853044

DOI 10.1128/mra.01130-22

Crossref 10.1128/mra.01130-22

pmc: PMC10019152

Publications 9.5.0